Skip to main content

Table 2 New and established diagnoses, treatment status at initial visit, and initiation of treatment within one year

From: Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems

Diagnosis Established Diagnoses (%) New Diagnoses (%) Receiving Treatment at Initial Visit (% of established diagnoses) Treatment Initiated: new and established diagnoses (%)
Psychiatric 78 (46%) 9 (5%) 33 (20%) 44 (77%)
Hepatitis C 62 (37%) 12 (7%) 0 (0%) 2 (3%)
Hypertension 28 (17%) 15 (9%) 10 (36%) 32 (76%)
Hyperlipidemia 9 (5%) 10 (6%) 4 (44%) 14 (74%)
HIV 7 (4%) 0 (0%) 1 (14%) 2 (29%)
Diabetes 4 (2%) 3 (2%) 2 (50%) 5 (71%)
Other 27 (16%) 5 (3%) 19 (11%) 11 (34%)
Total 215 (74%*) 54 (28%*) 69 (32%) 110 (41%)
  1. *Percentage with one or more diagnoses.